JPH11248710A5 - - Google Patents

Info

Publication number
JPH11248710A5
JPH11248710A5 JP1998364933A JP36493398A JPH11248710A5 JP H11248710 A5 JPH11248710 A5 JP H11248710A5 JP 1998364933 A JP1998364933 A JP 1998364933A JP 36493398 A JP36493398 A JP 36493398A JP H11248710 A5 JPH11248710 A5 JP H11248710A5
Authority
JP
Japan
Prior art keywords
nucleic acid
vzv
immunoreactive peptide
peptide
immunoreactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998364933A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11248710A (ja
JP4163799B2 (ja
Filing date
Publication date
Priority claimed from DE19757767A external-priority patent/DE19757767A1/de
Application filed filed Critical
Publication of JPH11248710A publication Critical patent/JPH11248710A/ja
Publication of JPH11248710A5 publication Critical patent/JPH11248710A5/ja
Application granted granted Critical
Publication of JP4163799B2 publication Critical patent/JP4163799B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP36493398A 1997-12-23 1998-12-22 水痘帯状疱疹ウイルス（ＶＺＶ）の糖タンパク質ｇｐＩＩの免疫反応性領域 Expired - Fee Related JP4163799B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757767:9 1997-12-23
DE19757767A DE19757767A1 (de) 1997-12-23 1997-12-23 Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Publications (3)

Publication Number Publication Date
JPH11248710A JPH11248710A (ja) 1999-09-17
JPH11248710A5 true JPH11248710A5 (enExample) 2006-02-02
JP4163799B2 JP4163799B2 (ja) 2008-10-08

Family

ID=7853319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36493398A Expired - Fee Related JP4163799B2 (ja) 1997-12-23 1998-12-22 水痘帯状疱疹ウイルス（ＶＺＶ）の糖タンパク質ｇｐＩＩの免疫反応性領域

Country Status (7)

Country Link
US (2) US6414116B1 (enExample)
EP (1) EP0927760B1 (enExample)
JP (1) JP4163799B2 (enExample)
AT (1) ATE453715T1 (enExample)
CA (1) CA2255101C (enExample)
DE (2) DE19757767A1 (enExample)
ES (1) ES2341061T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
JP2001074333A (ja) 1999-09-03 2001-03-23 Daikin Ind Ltd ヒートポンプ
CN1989789A (zh) * 2004-07-21 2007-06-27 皇家飞利浦电子股份有限公司 用于气体放电灯的多脉冲点火电路
US12569553B2 (en) 2020-03-09 2026-03-10 Dynavax Technologies Corporation Shingles vaccines comprising a TLR9 agonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717772A (en) 1971-09-03 1973-02-20 Midland Capital Corp Linear bidirectional scanning system
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
ATE116860T1 (de) * 1988-08-01 1995-01-15 Akzo Nobel Nv Pseudorabiesvirus-impfstoff.
ATE119939T1 (de) 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.
JPH07199A (ja) * 1993-06-18 1995-01-06 Teijin Ltd 水痘帯状疱疹ウイルス検出用プライマーセット及びそれを用いる同ウイルスの検出方法
DE19757767A1 (de) * 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)

Similar Documents

Publication Publication Date Title
WO2000053722A3 (en) Delivery of nucleic acids and proteins to cells
EP1004670A3 (en) Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
JP2001511347A5 (enExample)
WO2000026248A3 (en) Tuberculosis diagnostic test
EP1985705A3 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
SE9500023D0 (sv) Method of detecting cancer
AU2292601A (en) Novel cytokine zcyto18
CA2140794A1 (en) Assay for the determination of protein in a biological sample
RU95115686A (ru) Премерсацидин, промерсацидин, днк, вектор, клетка-хозяин, способ получения
Lemay et al. Human adenovirus type 2 protein IIIa I. Purification and characterization
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
CA2240409A1 (en) Mammalian cx3c chemokine genes
CA2199835A1 (en) Method for preparing nucleic acids for analysis and kits useful therefor
Kalmakoff et al. Physicochemical properties of Tipula iridescent virus
AU2400202A (en) Promoters exhibiting endothelial cell specificity and methods of using same
JPH11243974A5 (enExample)
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
EP0997476A3 (en) Antibodies to a mammalian Langerhans cell antigen and their uses
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
Haimo et al. Dynein binding to microtubules containing microtubule‐associated proteins
CA2255106A1 (en) Varicella zoster virus (vzv) immunoreactive protein vp26 and its diagnostic use
AU4969401A (en) Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
Werner et al. Fatigue crack growth properties of 1045 hot-rolled steel